 |
PDBsum entry 4zte
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cell adhesion
|
PDB id
|
|
|
|
4zte
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cell adhesion
|
 |
|
Title:
|
 |
Crystal structure of human e-cadherin (residues 3-213) in complex with a peptidomimetic inhibitor
|
|
Structure:
|
 |
Cadherin-1. Chain: a, b. Fragment: residues 157-367. Synonym: cam 120/80,epithelial cadherin,e-cadherin,uvomorulin. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cdh1, cdhe, uvo. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Expression_system_variant: plyss.
|
|
Resolution:
|
 |
|
2.13Å
|
R-factor:
|
0.187
|
R-free:
|
0.230
|
|
|
Authors:
|
 |
V.Nardone,A.P.Lucarelli,A.Dalle Vedove,E.Parisini
|
|
Key ref:
|
 |
V.Nardone
et al.
(2016).
Crystal Structure of Human E-Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive Inhibitor of Cadherin Homophilic Interaction.
J Med Chem,
59,
5089-5094.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-May-15
|
Release date:
|
01-Jun-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P12830
(CADH1_HUMAN) -
Cadherin-1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
882 a.a.
210 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Med Chem
59:5089-5094
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal Structure of Human E-Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive Inhibitor of Cadherin Homophilic Interaction.
|
|
V.Nardone,
A.P.Lucarelli,
A.Dalle Vedove,
R.Fanelli,
A.Tomassetti,
L.Belvisi,
M.Civera,
E.Parisini.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cadherins are transmembrane cell adhesion proteins whose aberrant expression
often correlates with cancer development and proliferation. We report the
crystal structure of an E-cadherin extracellular fragment in complex with a
peptidomimetic compound that was previously shown to partially inhibit cadherin
homophilic adhesion. The structure reveals an unexpected binding mode and allows
the identification of a druggable cadherin interface, thus paving the way to a
future structure-guided design of cell adhesion inhibitors against
cadherin-expressing solid tumors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |